Meet the people inside InSphero!
MBA-HSG, Chief Operating Officer & Member of the Management Team
10 years of professional experience in strategy consulting (L.E.K. Consulting / h&z Consulting), business development, commercial operations and medical devices (ConvaTec). Profound know-how in establishing and developing businesses on both, the strategic and operational level. She holds a Master of Business Administration (MBA) from University of St. Gallen (HSG).
MBA, Chief Financial Officer & Member of the Management Team
Qualified Accountant with over 25 years of experience at rapidly growing companies in the technology field. Expert in corporate finance including funding, corporate transactions and M&A. Experienced in systems integration and process reengineering.
Dr. Patrick Guye
Chief Scientific Officer & Member of the Management Team
Long-standing experience in life sciences, engineering, business innovation & development, operations and new ventures consulting. Leadership positions in industry (Sanofi) and in academia (Massachusetts Institute of Technology, Princeton University) with focus on cell therapy, 3D cellular models/organoids, synthetic biology, human stem cells, biologics and small molecules development and precision genomic engineering. PhD in Molecular Infection Biology from the University of Basel.
Director North American Business Operations InSphero Inc. USA & Member of the Management Team
Dynamic team leader with over 25 years of Life Science experience. I have a strong passion to advance the general understanding of in vitro microtissues/spheroids applications to better define drug efficacy and safety assessment.
A seasoned Quality Assurance and Regulatory Affairs professional with 20+ years of experience in pre-market and post-market product development of life science- & biotech products and medical devices, including medical device vigilance and postmarket surveillance. Hands-on experience in establishing Quality Systems supporting pre-clinical and clinical product development and product release to market.
Dr. Marion Bavand
Head of Quality Assurance & Member of the Management Team
Dr. Jens M. Kelm, Chief Technology Officer InSphero AG & Member of the Management Team
Dr. Jan Lichtenberg, Chief Executive Officer InSphero AG & Member of the Management Team
Thomas Pfisterer, Wild Group Management AG
Dr. Jürg Gysi, President of the Board, Switzerland
Former CEO, Promega AG Switzerland. Molecular Biologist with more than 30 years of experience in sales, marketing and management in the biotech industry in Switzerland, Germany and the US.
Beat Schillig, Founder and President IFJ Institute for Young Entrepreneurs
Serial Entrepreneur and Business Angel.
Dr. Thomas Rinderknecht, Senior Partner at Badertscher Rechtsanwälte
Has served on the boards of directors of several biotech, pharma and medtech companies, including amongst others Basilea, Speedel AG, Basel, Glycart Biotechnology AG and Ganymed Pharmaceuticals AG. Ph.D. in law from the University of Zurich, admitted to the Bar in Zurich.
Anna Evodokimova, VC Investment Director at Millhouse LLC
Professor Gordon McVie
Professor Gordon McVie (born 13 January 1945) is an international authority on the treatment and research of cancer. Along with Umberto Veronesi he is the founding editor of ecancermedicalscience, an open access cancer journal from the European Institute of Oncology in Milan.
Dr. Igor Koman
Dr. Igor Koman is the Director of Ariel University's Institute for Personalized Medicine. Dr. Komen graduated from the Russian Medical University and holds a PhD and DSc in clinical pharmacology.
Charles Qualls, DVM, PhD, DACVP
Dr. Qualls is a toxicology expert who retired as Executive Director of Investigative Toxicology and Pathology at Amgen Inc. Before working at Amgen, he served as Director of Molecular and Ultrastructural Pathology at GlaxoSmithKline. Dr. Qualls had a distinguished career over two decades in academia prior to moving into the pharmaceutical industry.
Dr. Jean Krutman
Professor Krutman is currently the scientific director of the Leibniz Research Institute for Environmental Medicine, Düsseldorf Germany.
Dr. Med. Sci. Frédéric Lévy
Head of Research & Evaluation at Debiopharm International SA and Associate Professor at the Faculty of Biology and Medicine, University of Lausanne with more than 50 peer-reviewed scientific publications. Dr Med Sc, Biochemistry/Immunology and Postdoc at California Institute of Technology